Cite
HARVARD Citation
Sun, R. et al. (2019). MiR‐22 and miR‐214 targeting BCL9L inhibit proliferation, metastasis, and epithelial‐mesenchymal transition by down‐regulating Wnt signaling in colon cancer. FASEB journal. 33 (4), pp. 5411-5424. [Online].